{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:03Z","timestamp":1790187063726,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2024J01044"],"award-info":[{"award-number":["2024J01044"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xiamen Natural Science Foundation Project","award":["3502Z202471020"],"award-info":[{"award-number":["3502Z202471020"]}]},{"name":"Xiang'an Innovation Lab Incubation Program","award":["2023XAKJ0101032"],"award-info":[{"award-number":["2023XAKJ0101032"]}]},{"name":"Funded by the National Key R&D Program","award":["2022YFC3603004"],"award-info":[{"award-number":["2022YFC3603004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25797-0","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:35:21Z","timestamp":1764840921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is the domestic bivalent HPV vaccine cost-effective compared with quadrivalent or nine-valent HPV vaccines in the context of cervical cancer screening? A modeling study"],"prefix":"10.1186","volume":"26","author":[{"given":"Liangwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaobin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"3","key":"25797_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"25797_CR2","unstructured":"World Health Organization. Cervical cancer. 2022-2-22. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"issue":"14","key":"25797_CR3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"384","author":"JY Lei","year":"2020","unstructured":"Lei JY, Ploner A, Elfstr\u00f6m KM, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;384(14):1340\u20138.","journal-title":"N Engl J Med"},{"key":"25797_CR4","unstructured":"World Health Organization. Cervical Cancer Elimination Initiative. https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative."},{"issue":"2","key":"25797_CR5","first-page":"214","volume":"27","author":"N Wang","year":"2021","unstructured":"Wang N, Lai Q, Li JH, et al. Status of vaccine integration into National immunization programs in 194 WHO member countries. China Vaccine Immun. 2021;27(2):214\u201320.","journal-title":"China Vaccine Immun"},{"key":"25797_CR6","unstructured":"World Health Organization. Immunization coverage.(2021-6-15)[2022-3-3]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage."},{"issue":"26","key":"25797_CR7","first-page":"2054","volume":"101","author":"DH Song","year":"2021","unstructured":"Song DH. Current status of global human papillomavirus vaccine immunization program inclusion and world health organization and united nations children\u2019s fund estimates of HPV vaccination coverage in various countries, 2010\u20132019. Chin Med J. 2021;101(26):2054\u20132054.","journal-title":"Chin Med J"},{"issue":"5","key":"25797_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, et al. Cancer statistics in China and the united States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584\u201390.","journal-title":"Chin Med J"},{"key":"25797_CR9","unstructured":"State Drug Administration. First domestic recombinant human papillomavirus vaccine approved for marketing. https:\/\/www.nmpa.gov.cn\/yaowen\/ypjgyw\/20191231160701608.html, 2019-12-31\/2022-3-3."},{"issue":"12","key":"25797_CR10","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S1473-3099(22)00435-2","volume":"22","author":"FH Zhao","year":"2022","unstructured":"Zhao FH, Wu T, Hu YM, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced human papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial. Lancet Infect Dis. 2022;22(12):1756\u201368.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"25797_CR11","first-page":"761","volume":"43","author":"H Chen","year":"2022","unstructured":"Chen H, Xia CF, Yuting T, et al. Reasons for the rapid rise in the burden of cervical cancer among Chinese women and its response. Chin J Epidemiol. 2022;43(5):761\u20135.","journal-title":"Chin J Epidemiol"},{"issue":"10","key":"25797_CR12","first-page":"1090","volume":"35","author":"SQ Zhang","year":"2019","unstructured":"Zhang SQ, Wang K, Zhang YL. Current status of HPV vaccine application in China. Chin J Pract Gynecol Obstet. 2019;35(10):1090\u20135.","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"24","key":"25797_CR13","first-page":"1869","volume":"101","author":"M Zhang","year":"2021","unstructured":"Zhang M, Bao HL, Wang LM, et al. Analysis of the current status of cervical cancer screening and related factors in China in 2015. Chin Med J. 2021;101(24):1869\u201374.","journal-title":"Chin Med J"},{"issue":"37","key":"25797_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.46234\/ccdcw2020.185","volume":"2","author":"B Song","year":"2020","unstructured":"Song B, Di J, Zhao G, et al. The utilization of health examination by menopausal and older women-6 provinces, China, 2018. China CDC Wkly. 2020;2(37):723\u20138.","journal-title":"China CDC Wkly"},{"key":"25797_CR15","unstructured":"World Health Organization. Human papillomavirus vaccines: WHO position paper. May 2022. (2022-12-16) [2022-12-17]. https:\/\/www.who.int\/publications\/i\/item\/who-wer9750."},{"key":"25797_CR16","unstructured":"Centers for Disease Control and Prevention. HPV and Men-Fact Sheet. https:\/\/www.cdc.gov\/std\/hpv\/stdfact-hpv-and-men.htm, 2022-1\u20133."},{"key":"25797_CR17","unstructured":"Gynecological Oncology Society of Chinese Medical Association, Chinese Society for Colposcopy and Cervical Pathology. Chinese Expert Consensus on Clinical Application of Human Papilloma Virus Vaccine. Med J of Peking Union Med College Hospital. 2021;12(2):189-201."},{"issue":"12","key":"25797_CR18","first-page":"1281","volume":"52","author":"SY Tao","year":"2018","unstructured":"Tao SY, Peng JR, Wang Y, Zhang GT, Chen ZY, Zhao F, et al. Study on the direct economic burden of patients with cervical cancer and precancerous lesions and the factors affecting it. Chin J Prev Med. 2018;52(12):1281\u20136.","journal-title":"Chin J Prev Med"},{"issue":"12","key":"25797_CR19","doi-asserted-by":"publisher","first-page":"10119","DOI":"10.1007\/s00432-023-04905-w","volume":"149","author":"S Wu","year":"2023","unstructured":"Wu S, Liang D, Shi J, et al. Evaluation of a population-based breast cancer screening in North China. J Cancer Res Clin Oncol. 2023;149(12):10119\u201330.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"25797_CR20","doi-asserted-by":"publisher","first-page":"e1335","DOI":"10.1016\/S2214-109X(20)30277-1","volume":"8","author":"Z Zou","year":"2020","unstructured":"Zou Z, Fairley CK, Ong JJ, et al. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Health. 2020;8(10):e1335\u201344.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"25797_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jnci\/djz074","volume":"112","author":"YL Qiao","year":"2020","unstructured":"Qiao YL, Wu T, Li RC, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J Natl Cancer Inst. 2020;112(2):145\u201353.","journal-title":"J Natl Cancer Inst"},{"key":"25797_CR22","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. (2021-7-6)[2022-12-17]. https:\/\/www.who.int\/publications\/i\/item\/9789240030824."},{"key":"25797_CR23","first-page":"74","volume-title":"A study on cervical cancer breast cancer screening strategy and health economics evaluation","author":"LL Han","year":"2019","unstructured":"Han LL, Kim SG. A study on cervical cancer breast cancer screening strategy and health economics evaluation. Beijing: Peking Union Medical College; 2019. pp. 74\u201395."},{"key":"25797_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100768","author":"M Gao","year":"2023","unstructured":"Gao M, Hu S, Zhao X, et al. Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study. The Lancet Regional Health. 2023. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100768.","journal-title":"The Lancet Regional Health"},{"key":"25797_CR25","doi-asserted-by":"publisher","unstructured":"Kiendr\u00e9b\u00e9ogo JA, Sidibe ARO, Compaor\u00e9 GB, et al. Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study. BMC Health Serv Res. 2023;23(1):1338. https:\/\/doi.org\/10.1186\/s12913-023-10283-3.","DOI":"10.1186\/s12913-023-10283-3"},{"issue":"1","key":"25797_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/ajco.13962","volume":"20","author":"S Arora","year":"2024","unstructured":"Arora S, Tuffaha H. Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India. Asia Pac J Clin Oncol. 2024;20(1):55\u201362.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"6","key":"25797_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10935-022-00697-w","volume":"43","author":"N Sargazi","year":"2022","unstructured":"Sargazi N, Takian A, Daroudi R, et al. Cost-benefit analysis of human papillomavirus vaccine in Iran. J Prev. 2022;43(6):841\u201357.","journal-title":"J Prev"},{"issue":"4","key":"25797_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/21645515.2020.1832835","volume":"17","author":"X Ma","year":"2021","unstructured":"Ma X, Harripersaud K, Smith K, et al. Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women. Hum Vaccin Immunother. 2021;17(4):1073\u201382.","journal-title":"Hum Vaccin Immunother"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25797-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25797-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25797-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:03:18Z","timestamp":1767837798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25797-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25797"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25797-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}